-
It has been fairly common to say that a shock with an automated external cardioverter (AED) must be given to someone experience cardiac arrest within a 10-minute window following initial attack.
-
A U.S. physician insists that current regulatory policies should be strengthened to ensure acceptable cardiovascular safety of medicines primarily developed for non-cardiovascular applications.
-
Robert Jarvik, MD, is a name known to many, for his development of the Jarvik 7 and the drama that was the life and death of retired dentist Barney Clark, the person first implanted with that first artificial heart in 1982.
-
Bristol-Myers Squibb (BMS; New York) reported in mid-December that it would sell its Medical Imaging (BMS-MI) unit in Billerica, Massachusetts, to private equity firm Avista Partners (New York) for $525 million in cash.
-
Boston Scientific (Natick, Massachusetts) reported that it has signed an agreement to sell its fluid management and venous access businesses for $425 million in cash to private equity firm Avista Capital Partners, thereby, it said last month, completing its program for spinning off what it termed "non-stategic" assets.
-
Abiomed (Danvers, Massachusetts) rang in year 2008 by issuing an update to its European strategy to drive growth by establishing the concept of recovery as the goal for patients experiencing acute cardiac events.
-
Affymetrix (Santa Clara, California) reported that the University of Ottawa Heart Institute (UOHI; Ottawa, Ontario) is using the Affymetrix Genome-Wide Human SNP (single nucleotide polymorphisms) Array 6.0 for its whole-genome association study on coronary artery disease (CAD).
-
SAN FRANCISCO Strung with white-and-turquoise canvas bags as they made their ways through the packed hallways of the Westin St. Francis hotel here, attendees took in the final full events of the 26th annual JPMorgan Healthcare Conference in early January.
-
Device and pharmaceutical company Angiotech Pharmaceuticals (Vancouver, British Columbia) has made good on what it promised early last year: to file for FDA clearance of its anti-infective 5-Fluorouracil-coated (5-FU) Central Venous Catheter (CVC) before year's end.
-
Stem cells where to get them and how to grow them into the right cell type have gotten much of the attention in the quest for making organs for transplantation. But getting any sort of tissue is not in itself enough: to grow an organ, the right cell types need to grow into the proper shape.
